US 11,253,572 K1 (3,909th)
	Use of a VEGF antagonist to treat angiogenic eye disorders
George Yancopoulos
Assigned to REGENERON PHARMACEUTICALS, INC.
Trial No. IPR2023-00884, Apr. 27, 2023
Trial No. IPR2024-00260, Dec. 14, 2023
Trial No. IPR2024-00298, Dec. 18, 2023
Inter Partes Review Certificate for Patent 11,253,572, issued Feb. 22, 2022, Appl. No. 17/352,892, Jun. 21, 2021
Inter Partes Review Certificate issued Feb. 27, 2025